What is more, the SE, SP, PPV, and NPV values of all newly tested parameters (CCL2, CCL4, CCL15) were higher than CA 19-9, which confirms their higher usefulness in case of patients with CRC than the routinely used marker. This evidence concerns the gene CCL4 and colorectal carcinoma.